DYN - Dyne Therapeutics, Inc.

QQQ $ 462.33 $ 11.20 (2.48 %)

DIA $ 397.90 $ 4.02 (1.02 %)

SPY $ 542.04 $ 8.77 (1.64 %)

TLT $ 97.28 $ 0.67 (0.69 %)

GLD $ 228.03 $ -0.35 (-0.15 %)

Previous Close

$ 43.64

Open

Bid

$ 43.60 x 100

Ask

$ 43.76 x 214

Day's Range

-- - --

52 Week Range

$ 6.40 - $ 45.46

Volume

962,308

Average Volume

Market Cap

4.04B

Beta (5Y Monthly)

$ 0.87

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-05-2024	12-31-2023	10-K
4	10-30-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-02-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-02-2022	03-31-2022	10-Q
11	03-10-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-04-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

tech-stocks-soar-treasury-yields-fall-on-cool-inflation-data-starbucks-rockets-chipotle-plummets-whats-driving-markets-tuesday

Tech Stocks Soar, Treasury Yields Fall On ...
08/13/2024 16:55:01

A wave of bullish sentiment swept through Wall Street on Tuesday after lower-than-expected producer inflation data solidified e...

Piper Sandler Maintains Overweight on Dyne...
08/13/2024 11:13:16

Piper Sandler analyst Edward Tenthoff maintains Dyne Therapeutics (NASDAQ:DYN) with a Overweight and raises the price target...

HC Wainwright & Co. Maintains Buy on Dyne ...
08/13/2024 10:35:28

HC Wainwright & Co. analyst Andrew Fein maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target ...

Dyne Therapeutics Expects Cash & Equivalen...
08/12/2024 21:21:59

Dyne Therapeutics Q2 2024 GAAP EPS $(0.70)...
08/12/2024 21:19:42

Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(0....

xpeng--quantumscape-are-among-top-11-mid-cap-stocks-that-performed-well-last-week-july-7-july-13-details

XPeng & QuantumScape Are Among Top 11 Mid ...
07/14/2024 17:22:37

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...

JP Morgan Maintains Overweight on Dyne The...
07/09/2024 15:01:22

JP Morgan analyst Tessa Romero maintains Dyne Therapeutics (NASDAQ:DYN) with a Overweight and raises the price target from $...

Dyne Therapeutics DYNE-302 Exhibited Prolo...
06/13/2024 20:43:53

caseys-reports-upbeat-earnings-joins-avidity-biosciences-rentokil-initial-and-other-big-stocks-moving-higher-on-wednesday

Casey's Reports Upbeat Earnings, Joins Avi...
06/12/2024 14:15:52

soft-inflation-data-boosts-small-caps-real-estate-regional-banks-traders-anticipate-fed-rate-cuts-as-stocks-react

Soft Inflation Data Boosts Small Caps, Rea...
06/12/2024 14:09:19

U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cu...

modine-manufacturing-posts-mixed-q4-results-joins-viasat-lululemon-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Modine Manufacturing Posts Mixed Q4 Result...
05/22/2024 09:44:03

Reported Earlier, Dyne Therapeutics Prices...
05/22/2024 07:09:19

The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses pay...

Chardan Capital Maintains Buy on Dyne Ther...
05/21/2024 12:15:54

Chardan Capital analyst Keay Nakae maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $31 ...

Dyne Therapeutics Announces $300M Public O...
05/20/2024 20:01:52

Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming...

why-is-dyne-therapeutics-stock-soaring-on-monday

Why Is Dyne Therapeutics Stock Soaring On ...
05/20/2024 19:53:38

Dyne Therapeutics reported promising Phase 1/2 trial data for DYNE-101 in myotonic dystrophy type 1 and DYNE-251 in Duchenne mu...

Jefferies Maintains Buy on Dyne Therapeuti...
05/20/2024 17:32:17

Jefferies maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $36 to $42.

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday

Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

HC Wainwright & Co. Maintains Buy on Dyne ...
05/20/2024 13:33:21

HC Wainwright & Co. analyst Andrew Fein maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target ...

Market-Moving News for May 20th
05/20/2024 12:37:59

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation NKGN: 81% | NK...

Dyne Therapeutics Announced Clinical Data ...
05/20/2024 10:33:32

In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 ...